CXCL10 drives pancreatic ductal adenocarcinoma progression through CXCR3-ERK/MAPK signaling
Cellular Signalling · 2026-10 · 146 · 112637
DOI: 10.1016/j.cellsig.2026.112637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Haomin Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian, China. Hauptthemen laut MEDLINE: Receptors, CXCR3, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Chemokine CXCL10. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Clinical Specialty Discipline Construction Program of China.
Abstract (Originalsprache)
The functional significance of the CXCL10/CXCR3 chemokine axis in pancreatic ductal adenocarcinoma (PDAC) remains incompletely defined. Through integrated analysis of clinical datasets, patient samples, and functional assays, we demonstrate that CXCL10 and CXCR3 are frequently overexpressed in PDAC, with high levels correlating with advanced disease and poorer overall survival. Notably, CXCR3 expression emerged as an independent prognostic indicator. Functionally, CXCL10 treatment or overexpression enhanced PDAC cell proliferation, migration, invasion, clonogenicity, and epithelial-mesenchymal transition (EMT). Conversely, CXCL10 knockdown or pharmacological CXCR3 inhibition with AMG487 suppressed these oncogenic phenotypes. Mechanistically, CXCL10 signaling activated the ERK/MAPK pathway, and ERK inhibition abolished its tumor-promoting effects. This study establishes that CXCL10 drives PDAC progression through CXCR3-dependent ERK/MAPK activation, positioning this axis as a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian, China.
- Department of Laboratory Medicine, Provincial Hospital of Fuzhou University, Fuzhou 350001, Fujian, China.
- Department of General Surgery, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian, China. Electronic address: fengchun160@fjmu.com.
Förderung
- National Key Clinical Specialty Discipline Construction Program of China
Zitieren
APA
Yuan, H., Wu, L., Song, Y., Lin, H., & Lu, F. (2026). CXCL10 drives pancreatic ductal adenocarcinoma progression through CXCR3-ERK/MAPK signaling. Cellular Signalling, 146, 112637. https://doi.org/10.1016/j.cellsig.2026.112637
Vancouver
Yuan H, Wu L, Song Y, Lin H, Lu F. CXCL10 drives pancreatic ductal adenocarcinoma progression through CXCR3-ERK/MAPK signaling. Cellular Signalling. 2026;146:112637. doi:10.1016/j.cellsig.2026.112637
BibTeX
@article{Yuan2026,
author = {Yuan, Haomin and Wu, Longhang and Song, Yu and Lin, Hongqin and Lu, Fengchun},
title = {CXCL10 drives pancreatic ductal adenocarcinoma progression through CXCR3-ERK/MAPK signaling},
journal = {Cellular Signalling},
year = {2026},
volume = {146},
pages = {112637},
doi = {10.1016/j.cellsig.2026.112637}
}
EUVIMED